Joe Walton
@cool_genes
If you wish to make an apple pie from scratch, you must first invent the universe. - Carl
ID: 1264960006467784706
25-05-2020 16:42:28
52 Tweet
91 Followers
331 Following
Check out our Nature Reviews Urology Perspective to learn more about the most common type of kidney cancer (ccRCC) and the molecular underpinnings of this disease. Huge thanks to @laillesuhnrese1, Keith Lawson, Cheryl Arrowsmith, Takis Prinos & Tony Finelli for your support!
For full text of our Nature Reviews Urology Perspective on the epigenetics of ccRCC: rdcu.be/cXJt0 @laillesuhnrese1, Keith Lawson, Cheryl Arrowsmith, Takis Prinos & Tony Finelli #cancerresearch #kidneycancer #epigenetics #UHN
📚PUBLISHED BY #CUASF winner! #kidneycancerresearch #epigenetics PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma >>nature.com/articles/s4158… Joe Walton Keith Lawson Cheryl Arrowsmith Takis Prinos Tony Finelli Gabriel Malouf Kidney Cancer Canada Nature Reviews Urology
Happy to share the discovery of the team of a novel epigenetic phenotype in clear-cell RCC charted by enhancer demethylation (TED), and associated with sarcomatoid dedifferentiation and resistance to IO. ncbi.nlm.nih.gov/pubmed/36374555 Clinical Cancer Research Toni Choueiri, MD IGBMC Fondation ARC -
From an extensive traveller in her childhood, to a world-class head and neck cancer researcher, Dr. Laurie Ailles Princess Margaret Cancer Centre weaves her passion with hard work and adaptability to seize opportunities that come to her. Read her career & life story here uhnresearch.ca/news/meet-laur…
The SGC 20th Anniversary Symposium Structural Genomics Consortium (SGC) is coming on March 8! The symposium will feature several talks on accelerating drug discovery in cancer, infectious diseases and more. Check out the event program here → thesgc.org/sgc-20th-anniv…
The SGC 20th Anniversary Symposium continues with Daniel De Carvalho and Joe Walton, from Princess Margaret Cancer Centre University Health Network, elucidating how probing the human epi(genome) have the potential to uncover therapeutic opportunities in cancer. #20yearsSGC
A fruitful collaboration with @laillesuhnrese1 and Joe Walton using the SGC's epigenetic #probes library. How did this work lead to the identification of the role of PRMT1 in clear cell renal carcinoma? Find the preprint: bit.ly/410cASO
🚨 Excited to share our new publication in Nature Communications on PRMT inhibition in kidney cancer! 🙌 Big thanks to @laillesuhnrese1, Structural Genomics Consortium (SGC), Cheryl Arrowsmith, Brian Raught, and the entire team!👏Read more here: nature.com/articles/s4146… #cancerresearch #kidneycancer #UHN
New therapeutic target for kidney cancer🎯 A team led by @laillesuhnrese1 University Health Network found that inhibiting the protein PRMT1 can shrink kidney tumours by disrupting RNA metabolism and creating DNA damage. This discovery paves the way for new treatment options. nature.com/articles/s4146…
New hope for kidney cancer patients! 🎗️ Researchers at Princess Margaret Cancer Centre Research discovered that blocking PRMT1, an epigenetic protein, causes kidney #cancer cells to self-destruct. This breakthrough could lead to new #treatments for the deadliest form of the disease. Learn more⬇️
Congratulations Sandy Serena !! 🤩 Amazing work!! 🥳
🧬 Breakthrough in #KidneyCancer research! Scientists Princess Margaret Cancer Centre Research have found a new treatment target for clear cell renal cell #carcinoma—PRMT1. Read about this target's role in regulating DNA & how this opens the door for future therapies ➡️ uhnresearch.ca/news/identifyi…
